Cargando…
UBE2C mediated radiotherapy resistance of head and neck squamous cell carcinoma by regulating oxidative-stress-relative apoptosis
Purpose: Radiotherapy resistance is the main obstacle in the effective treatment of advanced head and neck squamous cell carcinoma (HNSCC). Increasing scientific opinions present that ubiquitin-conjugating enzyme E2C (UBE2C) might be a target gene acting as an oncogene. Method: TCGA database was use...
Autores principales: | Zhou, Yingchun, Zhang, Junbin, Gong, Jinglin, Tang, Xi, Zhang, Chengyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512496/ https://www.ncbi.nlm.nih.gov/pubmed/36069832 http://dx.doi.org/10.18632/aging.204265 |
Ejemplares similares
-
Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma
por: Ye, Guo, et al.
Publicado: (2021) -
UBE2O Promotes Progression and Epithelial–Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Chen, Xiyu, et al.
Publicado: (2020) -
UBE2C triggers HIF‐1α‐glycolytic flux in head and neck squamous cell carcinoma
por: Yang, Yi‐Fang, et al.
Publicado: (2022) -
Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020) -
Development and Validation of an Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma
por: Liu, Chang, et al.
Publicado: (2021)